IMDX — Insight Molecular Diagnostics Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1642380 ·
Last close
$4.65
Market Cap
$150.15M
52W High
$6.86
52W Low
$3.87
ADV30
198,673
Next earnings
2026-08-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 32,000 | 15,000 | -10,331,000 | -4,290,000 | 40,427,000 | 28,201,000 | 51,118,000 |
| Dec 2025 | 1,139,000 | 496,000 | -9,950,000 | -22,955,000 | 25,756,000 | 11,583,000 | 57,220,000 |
| Sep 2025 | 260,000 | 139,000 | -7,670,000 | -10,854,000 | 43,937,000 | 18,692,000 | 53,133,000 |
| Jun 2025 | 518,000 | 350,000 | -6,971,000 | -9,742,000 | 50,517,000 | 24,287,000 | 49,419,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-23,984,000
Investing CF
$-3,491,000
Financing CF
$24,212,000
CapEx
$-3,491,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.48
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-405,051,000
Inventory
$382,000
Receivables
$157,000
ST Investments
—
EBIT TTM
$-47,738,000
Pretax Income TTM
$-47,841,000
Interest Exp TTM
$103,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,949,000
EBITDA
$-32,649,000
Free Cash Flow
$-15,659,625
Enterprise Value
$125,017,280
Total Cash
$28,201,000
Total Debt
$3,069,000
Shares Out
32,290,167
Trailing EPS
$-1.51
Book Value
$-0.33
ROE
—
ROA
-43.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,055,000 | -30,578,000 | -50,222,000 | 25,756,000 | 57,220,000 | — | -22,184,000 |
| Dec 2024 | 1,881,000 | -23,247,000 | -60,663,000 | 35,081,000 | 47,355,000 | — | -20,689,000 |
| Dec 2023 | 1,503,000 | -22,417,000 | -27,781,000 | 74,892,000 | 54,424,000 | — | -23,325,000 |
| Dec 2022 | 958,000 | -28,852,000 | -72,902,000 | 100,091,000 | 65,799,000 | — | -45,568,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.78
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $4.00 · spot: $4.65 · call volume: 158 · put volume: 17
Expected Move to 2026-09-18:
±$3.40
(73.12%) —
implied range
$1.25 –
$8.05
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | $112.48M | $1.05 | — |
| ICCC | IMMUCELL CORP /DE/ | $101.41M | $11.21 | — |
| TKNO | Alpha Teknova, Inc. | $268.07M | $5.00 | — |
| MYGN | MYRIAD GENETICS INC | $270.12M | $2.86 | — |
| OABI | OmniAb, Inc. | $287.05M | $1.98 | — |
News headlines (Yahoo Finance, 1h cache)
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
2026-07-23 12:00 · Yahoo
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
2026-07-16 19:22 · Yahoo
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
2026-06-29 12:00 · Yahoo
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
2026-06-22 18:07 · Yahoo
Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment
2026-06-19 18:17 · Yahoo
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
2026-06-16 20:05 · Yahoo
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
2026-06-11 20:17 · Yahoo
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
2026-06-09 20:05 · Yahoo
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With Fresh Capital And GraftAssureDx Submission
2026-05-15 13:16 · Yahoo
Insight Molecular Diagnostics Inc. Q1 2026 Earnings Call Summary
2026-05-14 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.